ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Tourmaline Bio Inc

Tourmaline Bio Inc (TRML)

25.835
-1.05
( -3.89% )
Updated: 10:05:15

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
25.835
Bid
25.77
Ask
25.95
Volume
8,053
25.37 Day's Range 26.86
12.12 52 Week Range 48.31
Market Cap
Previous Close
26.88
Open
26.46
Last Trade
100
@
25.835
Last Trade Time
10:05:14
Financial Volume
$ 207,728
VWAP
25.7952
Average Volume (3m)
222,237
Shares Outstanding
25,642,610
Dividend Yield
-
PE Ratio
-16.33
Earnings Per Share (EPS)
-1.64
Revenue
-
Net Profit
-42.12M

About Tourmaline Bio Inc

Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and ... Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Tourmaline Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TRML. The last closing price for Tourmaline Bio was $26.88. Over the last year, Tourmaline Bio shares have traded in a share price range of $ 12.12 to $ 48.31.

Tourmaline Bio currently has 25,642,610 shares outstanding. The market capitalization of Tourmaline Bio is $689.27 million. Tourmaline Bio has a price to earnings ratio (PE ratio) of -16.33.

TRML Latest News

Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024

NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...

Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

– On track to report topline data from Phase 2 TRANQUILITY trial in first half of 2025 – – Assembled Cardiovascular Scientific Advisory Board (CV SAB), comprised of leading academic and industry...

Tourmaline Bio to Present at Upcoming Investor Conferences

NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...

Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024

NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.535-5.6083302886427.3729.646125.3722246127.17554714CS
4-3.455-11.795834755929.2929.788325.116598827.25753264CS
1211.13575.748299319714.729.788314.2222223724.3456439CS
2610.93573.38926174514.929.788312.1224593218.4248124CS
529.08554.238805970116.7548.3112.1227776622.7900306CS
15615.515150.33914728710.3248.319.1826445322.61531073CS
26015.515150.33914728710.3248.319.1826445322.61531073CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CEROCERo Therapeutics Holdings Inc
$ 0.345
(84.29%)
545.19M
SPPLSIMPPLE Ltd
$ 1.3954
(58.03%)
70.26M
CELUCelularity Inc
$ 3.41
(51.56%)
2.13M
FCELFuelCell Energy Inc
$ 9.124
(30.16%)
4.46M
BENFBeneficient
$ 1.59
(27.20%)
72.7M
TFFPTFF Pharmaceuticals Inc
$ 0.3701
(-76.87%)
2.47M
EYENEyenovia Inc
$ 0.1028
(-69.77%)
14M
QUBTQuantum Computing Inc
$ 2.75
(-37.50%)
24.05M
APMAptorum Group Ltd
$ 0.70
(-36.36%)
82.83k
IPWiPower Inc
$ 0.7798
(-35.02%)
397.59k
CEROCERo Therapeutics Holdings Inc
$ 0.3421
(82.75%)
519.14M
ELABElevai Labs Inc
$ 0.02205
(-15.84%)
126.39M
BENFBeneficient
$ 1.585
(26.80%)
72.24M
SPPLSIMPPLE Ltd
$ 1.405
(59.12%)
69.12M
STISolidion Technology Inc
$ 0.411776
(17.65%)
55.18M